Table 2.
Complications by CKD stage within OA.
| Complication | OA alone (N = 4,246,648a) | Stage 1 (eGFR> 90 mL/min/1.73 m2) (N = 2176) | Stage 2 (eGFR 60–89 mL/min/1.73 m2) (N = 13,458) | Stage 3 (eGFR 30–59 mL/min/1.73 m2) (N = 69,601) | Stage 4 (eGFR 15–29 mL/min/1.73 m2) (N = 9907) | Stage 5 (eGFR< 15 mL/min/1.73 m2) (N = 817) | P-Valueb |
|---|---|---|---|---|---|---|---|
| Wound seroma or hematoma | 32491 (0.8%) | 20 (0.9%) | 74 (0.5%) | 752 (1.1%) | 178 (1.8%) | 20 (2.4%) | 0.0001 |
| Wound infection | 15044 (0.4%) | 5 (0.2%) | 94 (0.7%) | 323 (0.5%) | 54 (0.5%) | 0 (0.0%) | <0.0001 |
| Dislocation | 32392 (0.8%) | 41 (1.9%) | 163 (1.2%) | 889 (1.3%) | 175 (1.8%) | 10 (1.2%) | <0.0001 |
| Cardiac complications | 27224 (0.6%) | 27 (1.3%) | 97 (0.7%) | 856 (1.2%) | 113 (1.1%) | 4 (0.5%) | <0.0001 |
| Urinary complications | 85854 (2.0%) | 192 (8.8%) | 1507 (11.2%) | 11996 (17.2%) | 3036 (30.6%) | 210 (25.7%) | <0.0001 |
| Pulmonary complications | 21631 (0.5%) | 8 (0.4%) | 307 (2.3%) | 1243 (1.8%) | 268 (2.7%) | 30 (3.7%) | <0.0001 |
Sample size based on weighted frequencies, rounded to the nearest whole integer.
p-value from Rao-Scott chi-square test adjusted for sampling weights and design.